Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Research
| Technology Name (St. Jude Reference #) |
Minimized Liver Specific Promoter forImproved Gene Expression in Gene Therapy Vectors |
| Description | Improving expression levels is a key for making gene therapy work in humans. A liver specific promoter with regulatory regions minimized in size is provided. This promoter can be used to express any gene of interest in a size-constrained environment, such as in a self complementary gene therapy vector system. |
| Keywords | gene therapy |
| Granted Patents or Published Applications | U.S. Appln. No. 2008/0153156; pending European application |
| Related Scientific References | Nathwani, A.C. et al., “Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver”, Blood 107(7): 2653-61 (April 1, 2006). |
| Licensing Opportunities | This promoter has been licensed for use in gene therapy vectors to treat hemophilia B. We are currently seeking licensing opportunities for all other uses. |
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.
Last update: September 2008
